ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 177 filers reported holding ANTARES PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $58,000 | -93.8% | 14,150 | -94.5% | 0.01% | -91.6% |
| Q3 2021 | $934,000 | -10.9% | 256,622 | +6.8% | 0.10% | -19.5% |
| Q2 2021 | $1,048,000 | +158.8% | 240,303 | +143.7% | 0.12% | +76.1% |
| Q1 2021 | $405,000 | +34.1% | 98,620 | +30.2% | 0.07% | +36.7% |
| Q4 2020 | $302,000 | +184.9% | 75,726 | +92.1% | 0.05% | +172.2% |
| Q3 2020 | $106,000 | -87.4% | 39,419 | -89.0% | 0.02% | -91.5% |
| Q1 2020 | $844,000 | +848.3% | 357,789 | +1794.7% | 0.21% | +2020.0% |
| Q4 2019 | $89,000 | -18.3% | 18,884 | -41.9% | 0.01% | -33.3% |
| Q3 2019 | $109,000 | +113.7% | 32,496 | +71.9% | 0.02% | +150.0% |
| Q4 2018 | $51,000 | -90.1% | 18,903 | -91.9% | 0.01% | -77.8% |
| Q1 2018 | $513,000 | +12.7% | 233,300 | +2.1% | 0.03% | -3.6% |
| Q4 2017 | $455,000 | -22.9% | 228,500 | +25.5% | 0.03% | -30.0% |
| Q3 2017 | $590,000 | -9.4% | 182,075 | -9.9% | 0.04% | -4.8% |
| Q2 2017 | $651,000 | +135.0% | 202,160 | +97.6% | 0.04% | +281.8% |
| Q1 2015 | $277,000 | +177.0% | 102,316 | +162.2% | 0.01% | +57.1% |
| Q4 2014 | $100,000 | +13.6% | 39,016 | -18.7% | 0.01% | +40.0% |
| Q3 2014 | $88,000 | – | 48,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|